8RSM

Crystal structure of Streptococcus pyogenes macrodomain in complex with ADP-ribose

  • Classification: HYDROLASE
  • Organism(s): Streptococcus pyogenes
  • Expression System: Escherichia coli
  • Mutation(s): No 

  • Deposited: 2024-01-24 Released: 2024-09-25 
  • Deposition Author(s): Ariza, A.
  • Funding Organization(s): Wellcome Trust, Biotechnology and Biological Sciences Research Council (BBSRC), Medical Research Council (MRC, United Kingdom)

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.87 Å
  • R-Value Free: 0.201 
  • R-Value Work: 0.153 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history


Literature

Evolutionary and molecular basis of ADP-ribosylation reversal by zinc-dependent macrodomains.

Ariza, A.Liu, Q.Cowieson, N.Ahel, I.Filippov, D.V.Rack, J.G.M.

(2024) J Biol Chem : 107770-107770

  • DOI: https://doi.org/10.1016/j.jbc.2024.107770
  • Primary Citation of Related Structures:  
    8RSI, 8RSJ, 8RSK, 8RSL, 8RSM, 8RSN

  • PubMed Abstract: 

    Dynamic ADP-ribosylation signalling is a crucial pathway that controls fundamental cellular processes, in particular, the response to cellular stresses such as DNA damage, reactive oxygen species and infection. In some pathogenic microbes the response to oxidative stress is controlled by a SirTM/zinc-containing macrodomain (Zn-Macro) pair responsible for establishment and removal of the modification, respectively. Targeting this defence mechanism against the host's innate immune response may lead to novel approaches to support the fight against emerging antimicrobial resistance. Earlier studies suggested that Zn-Macros play a key role in the activation of this defence. Therefore, we used phylogenetic, biochemical, and structural approaches to elucidate the functional properties of these enzymes. Using the substrate mimetic asparagine-ADP-ribose as well as the ADP-ribose product, we characterise the catalytic role of the zinc ion in the removal of the ADP-ribosyl modification. Furthermore, we determined structural properties that contribute to substrate selectivity within the different Zn-Macro branches. Together, our data not only give new insights into the Zn-Macro family but also highlight their distinct features that may be exploited for the development of future therapies.


  • Organizational Affiliation

    School of Biosciences, University of Sheffield, Alfred Denny Building, Western Bank, Sheffield, S10 2TN, UK; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Protein-ADP-ribose hydrolase274Streptococcus pyogenesMutation(s): 0 
Gene Names: SPy_1216M5005_Spy0930
EC: 3.2.1
UniProt
Find proteins for Q99ZI6 (Streptococcus pyogenes serotype M1)
Explore Q99ZI6 
Go to UniProtKB:  Q99ZI6
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ99ZI6
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
AR6 (Subject of Investigation/LOI)
Query on AR6

Download Ideal Coordinates CCD File 
C [auth A][(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE
C15 H23 N5 O14 P2
SRNWOUGRCWSEMX-ZQSHOCFMSA-N
ZN
Query on ZN

Download Ideal Coordinates CCD File 
B [auth A]ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.87 Å
  • R-Value Free: 0.201 
  • R-Value Work: 0.153 
  • Space Group: P 41
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 41.704α = 90
b = 41.704β = 90
c = 137.895γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
xia2data reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data

  • Released Date: 2024-09-25 
  • Deposition Author(s): Ariza, A.

Funding OrganizationLocationGrant Number
Wellcome TrustUnited Kingdom210634
Biotechnology and Biological Sciences Research Council (BBSRC)United KingdomBB/R007195/1
Biotechnology and Biological Sciences Research Council (BBSRC)United KingdomBB/W016613/1
Medical Research Council (MRC, United Kingdom)United KingdomMR/X007472/1

Revision History  (Full details and data files)

  • Version 1.0: 2024-09-25
    Type: Initial release
  • Version 1.1: 2024-10-02
    Changes: Database references